Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afdbc4c89e2f0de0a30b63dcf7c1e955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d84d92eec9f232ace0dcb0df59c22c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2004-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768c1d51b86f0ccd4e5477c0e400ae27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a819483261de9d97312facde06ef6104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6fa789d03b141d2fac2003f6bd99d5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_211572238e419a5bf0f3aa44e13cb773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec10f75f8c65f901fcabca835c80835 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d812cbadefb865d193fc38a30792ff |
publicationDate |
2006-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1671645-A1 |
titleOfInvention |
Remedy and detection drug for bile duct cancer |
abstract |
Disclosed is a cholangiocarcinoma cell growth inhibitor comprising an anti-glypican-3 antibody as an active ingredient. Preferably, the anti-glypican-3 antibody has a cytotoxic activity such as an antibody-dependent cytotoxic (ADCC) activity and a complement-dependent cytotoxic (CDC) activity. Also disclosed is a diagnostic agent for diagnosis of cholangiocarcinoma comprising an anti-glypican-3 antibody. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7867734-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102739-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047291-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919086-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101605560-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10118959-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975966-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2054083-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871613-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2054083-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8153122-B2 |
priorityDate |
2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |